Promising long and short-term clinical data show potential of first ASD occluder with a bioresorbable, metal-free frame

atHeart Medical’s reSept ASD Occluder is designed to preserve patients’ future transseptal treatment options BAAR, Switzerland and SANTA CLARA, Calif., June 18, 2024 /PRNewswire/ — atHeart Medical, a medical device company establishing a new standard of care for atrial septal defects…